Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100

dc.contributor.authorReck, M.
dc.contributor.authorBarlesi, F.
dc.contributor.authorYang, , J. C.-H.
dc.contributor.authorWesteel, V.
dc.contributor.authorFelip, E.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorDols, M. Cobo
dc.contributor.authorSullivan, R.
dc.contributor.authorKowalski, D.
dc.contributor.authorAndric, Z.
dc.contributor.authorLee, D. H.
dc.contributor.authorSezer, A.
dc.contributor.authorShamrai, V.
dc.contributor.authorSzalai, Z.
dc.contributor.authorWang, X.
dc.contributor.authorXiong, H.
dc.contributor.authorJacob, N.
dc.contributor.authorMehr, K. Tadjalli
dc.contributor.authorPark, K.
dc.date.accessioned2022-11-04T10:13:33Z
dc.date.available2022-11-04T10:13:33Z
dc.date.issued2022
dc.identifier.endpage39en_US
dc.identifier.issn1556-0864en_US
dc.identifier.issue9en_US
dc.identifier.startpage39en_US
dc.identifier.urihttp://hdl.handle.net/11727/8005
dc.identifier.volume17en_US
dc.identifier.wos000858678100062en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF THORACIC ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectavelumaben_US
dc.subjectNSCLCen_US
dc.subjectfirst-lineen_US
dc.titleAvelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100en_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: